Sentence examples for markers to complement from inspiring English sources

Molecular markers to complement traditional breeding programs are being developed for genome mapping of agronomic traits.

The discovery of surrogate markers to complement or replace the counting of WBC in the staging of HAT is highly desired [11, 13, 14].

In the Branchiopoda, when multiple types of evidence are available (ecological and/or nuclear markers to complement mitochondrial DNA), divergences of >5% are typically indicative of different species [24], [28].

We had high expectations for the utility of these markers to complement the mtDNA barcode analysis based on our own experiences with other taxa [40], [41], the utility of these markers in other taxonomic groups where, for instance, ITS1 functions as a barcode [42], and, for 28S, based on predictions of others for the utility of this region as an alternative barcode region [43].

Although great efforts have been made to find new markers to complement or replace PSA, none has been fully validated or accepted.

In view of our phylogenetic test, single copy genes are good sources for molecular markers to complement data from chloroplast sequences and rDNA, yet the inclusion of intron sequences may produce artifacts.

These findings suggest the new COP-NLR as a new inflammation-based prognostic marker to complement classical tumour staging, reflecting biological changes related to high levels of IL-6 (the theoretically ideal marker of tumour-related SIR, whose serum levels are often difficult to be measured in the clinical practice).

Almost 200 published SSR primer pairs (Jia et al. 2007, 2009; Gupta et al. 2012) were tested on the parents, and a total of 126 informative markers were chosen to complement the SNP markers.

While all these markers can be used to complement current markers [42], the exploration of a large panel of protein markers to improve the differential diagnosis may rapidly become more cumbersome and less relevant than the study of the expression profile of selected genes, especially in the case of suspicious nodular thyroid lesions.

Candidate markers most likely to complement the ER were considered.

A new generation of drugs has been developed to selectively target such cancer-promoting pathways, (Druker et al, 2001; Hanahan & Weinberg, 2000; Weinstein, 2000) and hence treatment dictated by genetic markers is starting to complement the more conventional therapeutic approaches.